Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,794,212
  • Shares Outstanding, K 128,158
  • Annual Sales, $ 591,640 K
  • Annual Income, $ -87,970 K
  • EBIT $ -95 M
  • EBITDA $ -20 M
  • 60-Month Beta 1.19
  • Price/Sales 2.94
  • Price/Cash Flow 48.14
  • Price/Book 1.90

Options Overview Details

View History
  • Implied Volatility 57.83% ( +6.99%)
  • Historical Volatility 39.10%
  • IV Percentile 50%
  • IV Rank 48.62%
  • IV High 83.20% on 04/11/24
  • IV Low 33.83% on 09/10/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 430
  • Volume Avg (30-Day) 567
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 15,275
  • Open Int (30-Day) 14,690

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.05
  • Number of Estimates 5
  • High Estimate -0.04
  • Low Estimate -0.09
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.77 +9.63%
on 10/10/24
14.43 -2.95%
on 10/04/24
+0.19 (+1.38%)
since 10/01/24
3-Month
12.77 +9.63%
on 10/10/24
17.28 -18.98%
on 08/02/24
-3.50 (-20.00%)
since 08/01/24
52-Week
12.77 +9.63%
on 10/10/24
21.22 -34.02%
on 12/22/23
+0.23 (+1.67%)
since 11/01/23

Most Recent Stories

More News
Humacyte’s $30 Million Stock Offering Fuels Growth Despite Insider Concerns

Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte (HUMA) with a price target of $15.00, suggesting a significant upside for the company’s stock. Humacyte shares closed at $5.39 yesterday,...

HUMA : 5.39 (+6.73%)
EXAS : 69.80 (+1.26%)
NEO : 14.00 (+3.02%)
NeoGenomics: Q2 Earnings Snapshot

NeoGenomics: Q2 Earnings Snapshot

NEO : 14.00 (+3.02%)
NeoGenomics: Q1 Earnings Snapshot

NeoGenomics: Q1 Earnings Snapshot

NEO : 14.00 (+3.02%)
NeoGenomics: Q4 Earnings Snapshot

NeoGenomics: Q4 Earnings Snapshot

NEO : 14.00 (+3.02%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.0811 (-22.84%)
TELO.VN : 0.130 (-7.14%)
BMY : 54.32 (-2.60%)
TMO : 557.92 (+2.12%)
NTRA : 124.16 (+2.65%)
NEO : 14.00 (+3.02%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

TDSGF : 0.0811 (-22.84%)
TELO.VN : 0.130 (-7.14%)
BMY : 54.32 (-2.60%)
TMO : 557.92 (+2.12%)
NTRA : 124.16 (+2.65%)
NEO : 14.00 (+3.02%)
Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall, Thursday, 12/28/2023

Stocks that traded heavily or had substantial price changes on Thursday: Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall

ABX.TO : 26.60 (-1.15%)
BABA : 97.58 (-0.41%)
AMZN : 197.93 (+6.19%)
HES : 137.75 (+2.43%)
ATUS : 2.64 (+8.64%)
AAPL : 222.91 (-1.33%)
NEO : 14.00 (+3.02%)
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR® assay for minimal residual...

NEO : 14.00 (+3.02%)
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler...

NEO : 14.00 (+3.02%)
NeoGenomics: Q3 Earnings Snapshot

NeoGenomics: Q3 Earnings Snapshot

NEO : 14.00 (+3.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 15.00
2nd Resistance Point 14.67
1st Resistance Point 14.33
Last Price 14.00
1st Support Level 13.66
2nd Support Level 13.33
3rd Support Level 12.99

See More

52-Week High 21.22
Fibonacci 61.8% 17.99
Fibonacci 50% 16.99
Fibonacci 38.2% 16.00
Last Price 14.00
52-Week Low 12.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar